↓ Skip to main content

Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth

Overview of attention for article published in Cancer Immunology, Immunotherapy, January 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
5 patents

Citations

dimensions_citation
224 Dimensions

Readers on

mendeley
148 Mendeley
Title
Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth
Published in
Cancer Immunology, Immunotherapy, January 2012
DOI 10.1007/s00262-011-1178-0
Pubmed ID
Authors

Matthew R. Porembka, Jonathan B. Mitchem, Brian A. Belt, Chyi-Song Hsieh, Hyang-Mi Lee, John Herndon, William E. Gillanders, David C. Linehan, Peter Goedegebuure

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 148 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Netherlands 1 <1%
United Kingdom 1 <1%
Unknown 144 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 30 20%
Researcher 27 18%
Student > Bachelor 23 16%
Student > Doctoral Student 11 7%
Student > Master 9 6%
Other 21 14%
Unknown 27 18%
Readers by discipline Count As %
Medicine and Dentistry 46 31%
Agricultural and Biological Sciences 26 18%
Biochemistry, Genetics and Molecular Biology 18 12%
Immunology and Microbiology 17 11%
Pharmacology, Toxicology and Pharmaceutical Science 9 6%
Other 1 <1%
Unknown 31 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 February 2024.
All research outputs
#4,854,681
of 23,392,375 outputs
Outputs from Cancer Immunology, Immunotherapy
#512
of 2,926 outputs
Outputs of similar age
#41,737
of 247,189 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#8
of 31 outputs
Altmetric has tracked 23,392,375 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,926 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 247,189 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.